JFG
XENE icon

Jefferies Financial Group’s Xenon Pharmaceuticals XENE Stock Holding History

Jefferies Financial Group’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,000
Closed -$967K – 2090
2023
Q4 		$967K Buy
+21,000
New +$742K 0.01% 970
2023
Q2 		– Sell
-48,000
Closed -$1.72M – 2053
2023
Q1 		$1.72M Hold
48,000
– – 0.01% 711
2022
Q4 		$1.89M Buy
+48,000
New +$1.75M 0.01% 676

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jefferies Financial Group's XENE Position: Q4 2024 in Review

Jefferies Financial Group sold out of Xenon Pharmaceuticals (XENE) in Q4 2024, closing a stake of 66,500 shares — an estimated $2.62M sold.

Jefferies Financial Group first reported a position in XENE in Q4 2022 and held it in 7 quarters. The position peaked at $3.07M in Q4 2023. 209 funds tracked by Wall St. Rank hold XENE as of Q4 2024.

  • Jefferies Financial Group reported no remaining Xenon Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 66,500 Xenon Pharmaceuticals shares in Q4 2024, an estimated $2.62M.
  • Jefferies Financial Group first reported a position in Xenon Pharmaceuticals in Q4 2022 and held it in 7 quarters.
  • Jefferies Financial Group's Xenon Pharmaceuticals position peaked at $3.07M in Q4 2023.
  • 209 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2024.

Based on Jefferies Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.